ESSA Pharma (EPIX) Institutional Ownership → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free EPIX Stock Alerts $6.25 +0.05 (+0.81%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for ESSA Pharma (NASDAQ:EPIX)CurrentInstitutional OwnershipPercentage75.12%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$16.64MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$7.55M Get EPIX Insider Trade Alerts Want to know when executives and insiders are buying or selling ESSA Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EPIX Institutional Buying and Selling by Quarter Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit ESSA Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 Janus Henderson Group PLC1,175,242$9.98M0.0%+7.9%2.657% 5/15/2024 Bellevue Group AG7,889,583$66.98M1.0%-0.1%17.834% 5/14/2024 EntryPoint Capital LLC4,420$38K0.0%N/A0.010% 5/1/2024 BNP Paribas Financial Markets42,495$361K0.0%-26.1%0.096% 2/15/2024 PFM Health Sciences LP3,262,500$21.53M1.3%-22.3%7.388% 2/14/2024 RTW Investments LP2,298,662$15.17M0.2%N/A5.205% Get the Latest News and Ratings for EPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/7/2024 BNP Paribas Financial Markets57,466$379K0.0%+164.9%0.130% 11/15/2023 Rock Springs Capital Management LP677,005$2.09M0.1%+2.1%1.535% 11/9/2023 Group One Trading L.P.41,860$129K0.0%-14.2%0.095% 11/9/2023 Rhenman & Partners Asset Management AB234,000$723K0.1%-34.4%0.531% 8/14/2023 Rock Springs Capital Management LP663,317$1.79M0.0%+26.4%1.504% 8/14/2023 Driehaus Capital Management LLC28,300$76K0.0%-89.3%0.064% 8/11/2023 Cibc World Market Inc.160,643$434K0.0%-23.1%0.364% 7/26/2023 Privium Fund Management B.V.20,032$55K0.0%N/A0.045% 5/16/2023 Ally Bridge Group NY LLC236,583$703K0.9%-70.8%0.537% 5/12/2023 Rhenman & Partners Asset Management AB356,500$1.05M0.1%-4.9%0.809% 5/3/2023 Privium Fund Management UK Ltd20,032$61K0.0%N/A0.045% 2/15/2023 Avidity Partners Management LP1,855,400$4.68M0.1%-24.6%4.208% 2/14/2023 Driehaus Capital Management LLC264,571$667K0.0%N/A0.600% 2/3/2023 Frazier Life Sciences Management L.P.605,141$1.53M0.1%-12.7%1.373% 11/15/2022 PFM Health Sciences LP1,478,252$2.69M0.1%+53.7%3.354% 11/15/2022 Eventide Asset Management LLC1,561,251$2.84M0.1%-53.6%3.543% 11/15/2022 BVF Inc. IL8,748,629$15.92M0.7%+136.5%19.852% 11/15/2022 Bellevue Group AG5,898,583$10.74M0.2%+17.7%13.385% 11/15/2022 Bioimpact Capital LLC405,700$738K0.2%-38.6%0.921% 11/14/2022 RTW Investments LP1,311,294$2.39M0.1%-50.3%2.975% 11/10/2022 AlpInvest Partners B.V.39,930$73K0.0%-62.5%0.091% 8/12/2022 Ensign Peak Advisors Inc26,282$83K0.0%-70.6%0.060% 8/11/2022 Trexquant Investment LP19,147$60K0.0%+24.3%0.043% 8/11/2022 Alps Advisors Inc.26,140$82K0.0%N/A0.059% 8/10/2022 Cibc World Market Inc.94,578$298K0.0%-17.9%0.215% 8/8/2022 Walleye Capital LLC104,393$329K0.0%+75.8%0.237% 8/3/2022 Candriam S.C.A.567,343$1.79M0.0%-3.5%1.289% 5/17/2022 Eventide Asset Management LLC4,170,259$25.77M0.4%+25.7%9.474% 5/16/2022 Blackstone Inc.2,003,103$12.38M0.0%-39.4%4.551% 5/16/2022 Frazier Life Sciences Management L.P.692,910$4.28M0.4%N/A1.574% 5/9/2022 Qube Research & Technologies Ltd47,655$295K0.0%N/A0.108% 5/4/2022Prospera Financial Services Inc7,568$47K0.0%N/A0.017% 5/2/2022 Cannon Global Investment Management LLC15,300$95K0.1%N/A0.035% 4/27/2022 Alta Wealth Advisors LLC11,285$70K0.0%N/A0.026% Does this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit3/10/2022 Values First Advisors Inc.13,668$194K0.1%N/A0.031% 2/19/2022 Woodline Partners LP684,247$9.72M0.1%+286.6%1.556% 2/15/2022 CIBC World Markets Inc.84,230$1.20M0.0%N/A0.192% 2/14/2022 Virtus ETF Advisers LLC13,643$194K0.1%+74.3%0.031% 2/14/2022 Altium Capital Management LP345,000$4.90M1.4%N/A0.784% 2/14/2022 Boxer Capital LLC724,500$10.29M0.4%+5.5%1.647% 2/14/2022 Soleus Capital Management L.P.3,525,457$50.06M5.0%+22.9%8.015% 2/14/2022 Eventide Asset Management LLC3,318,647$47.13M0.6%+52.2%7.545% 2/11/2022 Ensign Peak Advisors Inc89,448$1.27M0.0%+7.7%0.203% 2/11/2022 Bioimpact Capital LLC668,688$9.50M1.7%-2.1%1.520% 2/10/2022 Candriam Luxembourg S.C.A.626,276$8.89M0.1%+108.4%1.424% 2/8/2022Frazier Management LLC543,470$7.72M0.6%+51.7%1.236% 2/8/2022 Swiss National Bank53,200$755K0.0%+8.4%0.121% 2/3/2022 Advisor Group Holdings Inc.4,559$65K0.0%-28.8%0.010% 12/17/2021Jefferies Group LLC62,502$500K0.0%N/A0.142% 11/16/2021 Schonfeld Strategic Advisors LLC10,600$85K0.0%-87.8%0.024% 11/16/2021 Janus Henderson Group PLC3,477,844$27.84M0.0%+72.4%7.907% 11/16/2021 Two Sigma Advisers LP564,800$4.52M0.0%+1,319.1%1.284% 11/16/2021 Two Sigma Investments LP502,406$4.02M0.0%+1,658.9%1.142% 11/16/2021 BVF Inc. IL2,851,461$22.81M0.9%+16.3%6.483% 11/16/2021 BioImpact Capital LLC683,287$5.47M0.8%N/A1.553% 11/16/2021 Citadel Advisors LLC685,531$5.49M0.0%-4.9%1.559% 11/15/2021 RTW Investments LP2,637,192$21.10M0.3%-13.6%5.996% 11/15/2021 Rock Springs Capital Management LP508,044$4.06M0.1%+1.0%1.155% 11/15/2021 Sphera Funds Management LTD.469,402$3.76M0.3%-27.6%1.067% 11/15/2021 HighVista Strategies LLC143,566$1.15M0.8%+497.5%0.326% 11/15/2021 Ensign Peak Advisors Inc83,068$665K0.0%-53.4%0.189% 11/12/2021 Renaissance Technologies LLC141,500$1.13M0.0%+618.3%0.322% 11/12/2021 Macquarie Group Ltd.6,106$49K0.0%N/A0.014% 11/12/2021 Credit Suisse AG13,713$110K0.0%+12.2%0.031% 11/12/2021 Oppenheimer & Co. Inc.47,300$378K0.0%N/A0.108% 11/12/2021 Bellevue Group AG5,034,814$40.28M0.4%+104.7%11.447% 11/12/2021 Rhenman & Partners Asset Management AB600,000$4.80M0.3%+130.8%1.364% 11/10/2021 Goldman Sachs Group Inc.121,601$973K0.0%+82.1%0.276% 11/10/2021 Alliancebernstein L.P.49,231$394K0.0%+212.7%0.112% 11/9/2021 Barclays PLC77,300$618K0.0%N/A0.176% 11/9/2021 BlackRock Inc.81,638$653K0.0%+23.0%0.186% 11/8/2021 Swiss National Bank49,100$393K0.0%+4.2%0.112% 11/5/2021 Advisor Group Holdings Inc.6,401$51K0.0%-72.4%0.015% 11/4/2021 Deutsche Bank AG43,701$350K0.0%+2,696.0%0.099% 8/25/2021 Marshall Wace LLP14,479$414K0.0%N/A0.036% 8/25/2021Marshall Wace North America L.P.273,413$7.81M0.0%+50.2%0.676% 8/17/2021 Sphera Funds Management LTD.648,303$18.52M1.3%+38.2%1.602% 8/17/2021 Price T Rowe Associates Inc. MD24,303$694K0.0%N/A0.060% 8/17/2021 Acuta Capital Partners LLC232,896$6.65M2.7%-18.9%0.576% 8/17/2021 BVF Inc. IL2,451,561$70.04M2.6%-15.7%6.060% 8/17/2021 Citadel Advisors LLC720,701$20.59M0.0%+48.1%1.781% 8/16/2021 Blackstone Inc3,303,103$94.37M0.2%-7.6%8.165% 8/16/2021 Commodore Capital LP281,911$8.05M2.8%+59.4%0.697% 8/16/2021 Morgan Stanley496,809$14.19M0.0%-13.3%1.228% “Dollar Will Be Worth NOTHING” -Musk (Ad)Elon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now.8/16/2021 Credit Suisse AG12,226$348K0.0%N/A0.030% 8/16/2021 Schonfeld Strategic Advisors LLC87,056$2.49M0.0%-14.8%0.215% 8/16/2021 Maven Securities LTD17,711$512K0.0%-36.9%0.044% 8/16/2021 Omega Fund Management LLC328,196$9.38M1.6%-2.6%0.811% 8/16/2021 Goldman Sachs Group Inc.66,774$1.91M0.0%+62.9%0.165% 8/16/2021 Marshall Wace LLP14,479$414K0.0%N/A0.036% 8/13/2021 RTW Investments LP3,053,919$87.25M1.3%+976.5%7.549% 8/13/2021 Renaissance Technologies LLC19,700$563K0.0%-73.9%0.049% 8/13/2021 Northern Trust Corp28,957$827K0.0%+140.2%0.072% 8/13/2021 Altium Capital Management LP213,528$6.10M1.4%-7.2%0.528% (Data available from 1/1/2016 forward) EPIX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EPIX shares? During the previous two years, 25 institutional investors and hedge funds held shares of ESSA Pharma. The most heavily invested institutionals were Bellevue Group AG ($66.98M), PFM Health Sciences LP ($21.53M), BVF Inc. IL ($15.92M), RTW Investments LP ($15.17M), Janus Henderson Group PLC ($9.98M), Avidity Partners Management LP ($4.68M), and Eventide Asset Management LLC ($2.84M).Learn more on EPIX's institutional investors. What percentage of ESSA Pharma stock is owned by institutional investors? 75.12% of ESSA Pharma stock is owned by institutional investors. Learn more on EPIX's institutional investor holdings. Which institutional investors have been buying ESSA Pharma stock? Of the 15 institutional investors that purchased ESSA Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($5.05M), RTW Investments LP ($2.30M), Bellevue Group AG ($888.87K), Eventide Asset Management LLC ($851.61K), PFM Health Sciences LP ($516.54K), Driehaus Capital Management LLC ($264.57K), and Rock Springs Capital Management LP ($152.06K). How much institutional buying is happening at ESSA Pharma? Institutional investors have bought a total of 10,263,216 shares in the last 24 months. This purchase volume represents approximately $34.62M in transactions. Which ESSA Pharma major shareholders have been selling company stock? Of the 16 institutional investors that sold ESSA Pharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Eventide Asset Management LLC ($1.80M), RTW Investments LP ($1.33M), PFM Health Sciences LP ($936.75K), Avidity Partners Management LP ($604.60K), Ally Bridge Group NY LLC ($574.97K), Bioimpact Capital LLC ($255.19K), and Driehaus Capital Management LLC ($236.27K). How much institutional selling is happening at ESSA Pharma? Institutional investors have sold a total of 6,216,801 shares in the last 24 months. This volume of shares sold represents approximately $17.67M in transactions. Related Companies: Emergent BioSolutions Major Shareholders XBiotech Major Shareholders Akebia Therapeutics Major Shareholders Immutep Major Shareholders Design Therapeutics Major Shareholders MacroGenics Major Shareholders Xeris Biopharma Major Shareholders Enanta Pharmaceuticals Major Shareholders Aldeyra Therapeutics Major Shareholders Pyxis Oncology Major Shareholders This page (NASDAQ:EPIX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate Capital348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.